Biocompare.com News Feeds

Biocompare.com RSS feed

02/09/2010 02:36 AM
Volk Extends Service in Latin America and Caribbean
Mentor, Ohio (February 4, 2010) - Volk Optical, the leader in the ophthalmic lens industry, is expanding its global territory with the appointment of Jorge Fernandez to the newly created position of Regional Business Manager, Latin America and Caribbean.

02/08/2010 08:33 PM
Younger Cataract Patients Report Better Vision Than Older Patients At 10 Years Postop
Cataract patients younger than 65 years at the time of surgery showed more stable self-reported and clinically evaluated visual function than an older comparator group at 10 years out, according to a study.

02/08/2010 08:26 PM
Computer Simulation Tool Supplements Residents' Training In Cataract Surgery
The Massachusetts Eye and Ear Infirmary Cataract Surgery Trainer, a virtual training tool which helps to train physicians to perform cataract surgery, has been shown to enhance teaching in cataract surgery when compared to traditional teaching methods. The results of a multi-center study evaluating the program's effectiveness as a supplement to traditional teaching tools was published in the February issue of Ophthalmology.

02/08/2010 04:55 PM
3SBio And Panacor Bioscience Enter Collaboration And License Agreement To Develop And Commercialize Nephoxil® For Hyperphosphatemia
3SBio Inc. ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced a collaboration and license agreement with Panacor Bioscience Ltd. to develop and commercialize its Nephoxil® pharmaceutical product for the treatment of hyperphosphatemia in China.

02/08/2010 04:55 PM
GeoVax Labs, Inc. Begins Enrollment At Final Site For Preventative Vaccine; Next Step Is To Submit IND Application For Therapeutic Vaccine To FDA
GeoVax Labs, Inc. (the "Company"), an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today provided an update on its vaccine trials progress.

02/08/2010 04:55 PM
Cara Therapeutics Reports Positive Phase II Data For Novel Peripheral Analgesic In Acute Post-Operative Pain
Cara Therapeutics, Inc. today announced positive data in a Phase II proof-of-concept clinical trial of its peripherally-restricted kappa opioid agonist, CR845. The 46 patient Phase II, multi-center, double-blind, placebo-controlled study was conducted at eight hospitals in the United States and evaluated the efficacy and safety of CR845 in women following laparoscopic-assisted hysterectomy. Subjects were administered a single intravenous infusion of 0.040 mg/kg CR845 or placebo following surgery, upon reporting a moderate-to-severe pain intensity level of 5 to 8 on a 0-10 pain scale. Analgesia was first assessed by pain intensity measurements for up to 8 hours post-infusion or until the patient requested morphine by initiation of patient-controlled analgesia (PCA morphine). Subsequently, analgesia was assessed by the amount of morphine required to alleviate pain until 16 hrs after drug administration.

02/08/2010 04:55 PM
Yale New Haven Health System Selects Brainware For AP Automation
Brainware, Inc., an innovative provider of intelligent data capture and enterprise search solutions, today announced that Yale New Haven Health System has selected the company's Brainware Distiller? solution to automate the extraction of data from invoices. At Yale New Haven Health System, Brainware Distiller will seamlessly integrate with the Lawson Enterprise Resource Planning (ERP) system and Perceptive Software's ImageNow Enterprise Content Management (ECM) solution.

02/08/2010 04:55 PM
Prevention Is The New Rx
The standard American diet, combined with inactivity and other unhealthy lifestyle behaviors, contributes to an excessive number of premature deaths in this country, according to leading preventive cardiology experts speaking at the American College of Cardiology's Fourth Annual Heart of Women's Health Conference in Washington, D.C.

02/08/2010 04:55 PM
Biocell Center Furthers Its Commitment To Maternal-Fetal Medicine
Biocell Center announced today its further commitment to working with maternal-fetal-medicine doctors by attending the Society for Maternal-Fetal Medicine's (SMFM) annual meeting.

02/08/2010 04:55 PM
BD Announces Worldwide Voluntary Recall Of BD Q-Syte? Luer Access Devices And BD Nexiva? Closed IV Catheter Systems
BD (Becton, Dickinson and Company) has voluntarily executed a product recall of certain lots of BD Q-Syte? Luer Access Devices and BD Nexiva? Closed IV Catheter Systems. Use of the affected devices may cause an air embolism or leakage of blood and/or therapy, which may result in serious injury or death. This field corrective action included notification to customers worldwide by letter. Neither the costs anticipated with the recall, nor the impact on BD's business, are expected to be material.